Publication

This publication examines the characteristics of public-private partnerships (PPPs) that aim to improve the health of the poor. It focuses on the role of product development partnerships (PDPs) as mechanisms for increasing access to essential drugs. The authors call for greater and more sustainable financing of PDPs, better mechanisms for coordination and a strengthening of organizational capacities. They also emphasize the need for legislative, regulatory and service infrastructures and assessment as well as for frameworks to ensure that the new products are effective, safe, affordable and accessible.